|国家科技期刊平台
首页|期刊导航|中国药业|药师干预对外科手术人血白蛋白使用的影响

药师干预对外科手术人血白蛋白使用的影响OACSTPCD

Effect of Pharmacists' Intervention on the Use of Human Serum Albumin in Surgery

中文摘要英文摘要

目的 探讨外科手术人血白蛋白(HSA)使用中药师干预的作用.方法 依据国内外指南,并结合医院实际制订HSA点评标准,临床药师据此对HSA的使用进行干预.分别抽取干预前后首都医科大学附属北京胸科医院外科手术病例 1632例(2021年 1月至 7月)和 3 205 例(2021 年 8 月至 2022 年 8 月),比较干预前后患者的性别、年龄、住院天数、手术类别、切口愈合等级(≥2级)占比、HSA的使用情况,进行合理性评价,并评估点评效果.结果 干预前后患者的性别、年龄、手术类别(胸外科和骨科)、切口愈合等级均无显著差异(P>0.05).与干预前比较,干预后患者的住院天数明显减少(P<0.01).HSA人均用量由干预前的(64.5±43.8)g减至干预后的(54.1±50.7)g,使用率由 70.77%降至 26.83%,不合理使用率由 95.67%降至 42.09%,差异均有统计学意义(P<0.01).干预后,HSA费用大幅降低[(2 272±2 132)元比(2 709±1 841)元,P<0.01],且排名由干预前的第 5 降至干预后的第 18,总体费用、药费和药占比也随之减少.结论 药师干预外科手术中HSA的使用,手术患者在住院时间减少的情况下,可减少HSA的平均用量,并降低其使用率和不合理使用率,以及减少患者的总费用、药费和药占比.

Objective To investigate the effect of pharmacists'intervention on the use of human serum albumin(HSA)in surgery.Methods According to the domestic,foreign guidelines and the actual status of the hospital,the comment standards of HSA were formulated,on the basis,the use of HSA was intervened by clinical pharmacists.A total of 1 632 cases underwent surgery(from January to July 2021,before the intervention)and 3 205 cases underwent surgery(from August 2021 to August 2022,after the intervention)in the Beijing Chest Hospital Affiliated to Capital Medical University were selected.The patients'gender,age,hospital stay,surgical category,proportion of wound healing≥grade two and use of HSA before and after the intervention were compared,the rationality of HSA use and comment effect was evaluated.Results There was no significant difference in patients'gender,age,surgical category of thoracic surgery and orthopedics and proportion of wound healing≥grade two before and after the intervention(P>0.05).Compared with that before intervention,the hospital stay of patients after intervention significantly decreased(P<0.01).The HSA dosage per capita significantly decreased from(64.5±43.8)g before intervention to(54.1±50.7)g after intervention,its use rate significantly decreased from 70.77%to 26.83%,and its irrational use rate significantly decreased from 95.67%to 42.09%(P<0.01).The HSA costs significantly decreased from CNY(2 709±1 841)before intervention to CNY(2 272±2 132)after intervention(P<0.01),with the ranking decreasing from the fifth before intervention to the eighteenth after intervention,the total costs,drug costs and drug proportion also decreased accordingly.Conclusion When the hospital stay decreases,the pharmacists'intervention on the use of HSA in surgery can decrease the average dosage,use rate and irrational use rate of HSA,as well as the patients'total cost,drug costs and drug proportion.

穆晓攀;孙阿宁;徐建;程凯;李茜茜;赵志刚

首都医科大学药学院,北京 100069||首都医科大学附属北京胸科医院·北京市结核病胸部肿瘤研究所,北京 101149首都医科大学附属北京天坛医院,北京 100070首都医科大学附属北京胸科医院·北京市结核病胸部肿瘤研究所,北京 101149

药学

药师人血白蛋白外科手术合理用药药品费用药事管理

pharmacisthuman serum albuminsurgeryrational drug usedrug costpharmaceutical administration

《中国药业》 2024 (002)

29-31 / 3

北京市通州区首批"两高"人才计划[通人才字[2017]10号].

10.3969/j.issn.1006-4931.2024.02.007

评论